{"transactions":[{"id":3113635,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":148531,"kind":"person","name":"Johnson Jeffrey D","position":1,"cik":"0001775039","reported_name":"Johnson Jeffrey D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-11T21:16:13.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":104000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in four equal annual installments beginning on June 9, 2020."}],"balance_after":119000,"source":{"system":"sec-edgar","filing":"0001209191-20-036002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000120919120036002/doc4.xml","form_type":"4"}},{"id":3327464,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":148531,"kind":"person","name":"Johnson Jeffrey D","position":1,"cik":"0001775039","reported_name":"Johnson Jeffrey D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-02T23:13:07.000Z","date":"2019-12-30","kind":"grant","acquired":true,"shares":43928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options shall vest: (a) with respect to 75% of the shares at such time as the price of the Company's Common Stock equals or exceeds $5.00 per share, (b) with respect to 15% of the shares at such time as the price of the Company's Common Stock equals or exceeds $7.00 per share; and (c) with respect to 10% of the shares at such time as the price of the Company's Common Stock equals or exceeds $8.00 per share, provided that all shares shall vest in full upon consummation of a change in control transaction."}],"balance_after":43928,"derivative":{"exercise_price":3.87,"expiration_date":"2029-12-29","underlying":"Common Stock","underlying_shares":43928},"source":{"system":"sec-edgar","filing":"0001209191-20-000420","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000120919120000420/doc4.xml","form_type":"4"}},{"id":3370095,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":148531,"kind":"person","name":"Johnson Jeffrey D","position":1,"cik":"0001775039","reported_name":"Johnson Jeffrey D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-15T23:42:52.000Z","date":"2019-11-13","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (the \"RSU\") that vest in three equal annual installments beginning on May 9, 2019, subject to continued service.  The RSU is the initial equity grant to which each non-employee director is entitled for service on the Issuer's board of directors pursuant to the non-employee director compensation policy that has been approved by the compensation committee of the Issuer's board of directors. The number of shares subject to the RSU was determined by reference to the price of the Issuer's common stock in its initial public offering, or $11 per share."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-19-056817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000120919119056817/doc4.xml","form_type":"4"}}]}